The 2018 AHA/ACC Guideline on the Management of Blood Cholesterol was a welcome update from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular ...

Lipoprotein (a) (Lp [a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo [a]), a plasminogen-like protein that ...

Contact: Olivia Walther, owalther@acc.org, WASHINGTON (Nov 15, 2024) - More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, ...

Get coverage of important new developments in cardiology ...

TRANSFORMING CARDIOVASCULAR CARE FOR ALL STARTS HERE! Join the American College of Cardiology (ACC) and the Singapore Cardiac Society for ACC Asia 2025 Together With SCS 36th Annual Scientific Meeting ...

Introduction and Scope of the Problem The incidence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep venous thromboembolism (DVT), in the United States is unclear because ...

Get more than $6,800 of education per person for everyone at your institution for one low price! That's over 500 Hours of CME Credit and 200 MOC Points! Get connected today with CardioSource® Plus, ...

NCD Academy is an online platform designed to empower the global primary care community with the knowledge, tools, and skills required to effectively address and mitigate the leading risk factors of ...

The following are key points to remember from a 2023 ACC Expert Consensus Decision Pathway on management of heart failure with preserved ejection fraction (HFpEF): Heart failure with preserved ...

Join Us When you become a member of the American College of Cardiology, you join a global community of cardiovascular professionals driven to transform cardiovascular care and improve heart health.

Contact: Nicole Napoli, nnapoli@acc.org, WASHINGTON (Mar 25, 2025) - Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which ...

Contact: Nicole Napoli, nnapoli@acc.org, LONDON (Aug 30, 2024) - Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits ...